Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice.
暂无分享,去创建一个
[1] P. Watkins,et al. Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. , 1997, Drug metabolism and disposition: the biological fate of chemicals.
[2] S. Krähenbühl,et al. Interaction between grapefruit juice and midazolam in humans , 1995, Clinical pharmacology and therapeutics.
[3] A. Walan. Clinical experience with omeprazole: assessment of efficacy and safety. , 1989, Journal of gastroenterology and hepatology.
[4] W. Legrum,et al. The character of inhibition of the metabolism of 1,2-benzopyrone (coumarin) by grapefruit juice in human , 1997, European Journal of Clinical Pharmacology.
[5] Y. Oshima,et al. Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction. , 1997, Pharmacogenetics.
[6] J. Miners,et al. Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism. , 1993, British journal of clinical pharmacology.
[7] T. Tomson,et al. Carbamazepine treatment induces the CYP3A4 catalysed sulphoxidation of omeprazole, but has no or less effect on hydroxylation via CYP2C19. , 2003, British journal of clinical pharmacology.
[8] R. Benton,et al. Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram , 1996, Clinical pharmacology and therapeutics.
[9] J. Miners,et al. Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism. , 1994, British journal of clinical pharmacology.
[10] Morton B. Brown,et al. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. , 1997, The Journal of clinical investigation.
[11] L. Bertilsson,et al. Interphenotype differences in disposition and effect on gastrin levels of omeprazole--suitability of omeprazole as a probe for CYP2C19. , 1995, British journal of clinical pharmacology.
[12] S. Higuchi,et al. Pharmacokinetics of omeprazole (a substrate of CYP2C19) and comparison with two mutant alleles, CYP2C19m1 in exon 5 and CYP2C19m2 in exon 4, in Japanese subjects , 1996 .
[13] T. Hedner,et al. Inhibition of 17 beta-estradiol metabolism by grapefruit juice in ovariectomized women. , 1994, Maturitas.
[14] B. Edgar,et al. Grapefruit juice and cimetidine inhibit stereoselective metabolism of nitrendipine in humans , 1991, Clinical pharmacology and therapeutics.
[15] P. Neuvonen,et al. Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice , 1995, Clinical pharmacology and therapeutics.
[16] L. Bertilsson,et al. Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators. , 1990, Therapeutic drug monitoring.
[17] C. Regårdh,et al. Effects of grapefruit juice ingestion – pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men , 1997, European Journal of Clinical Pharmacology.
[18] K. Chiba,et al. Disposition kinetics and metabolism of omeprazole in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation recruited from an Oriental population. , 1992, The Journal of pharmacology and experimental therapeutics.
[19] D. Bailey,et al. Grapefruit juice-drug interactions. , 1998, British journal of clinical pharmacology.
[20] D. Bailey,et al. Grapefruit juice–felodipine interaction: Mechanism, predictability, and effect of naringin , 1993, Clinical pharmacology and therapeutics.
[21] Kaoru Kobayashi,et al. Simultaneous determination of omeprazole and its metabolites in plasma and urine by reversed-phase high-performance liquid chromatography with an alkaline-resistant polymer-coated C18 column. , 1992, Journal of chromatography.
[22] M. Ducharme,et al. Disposition of intravenous and oral cyclosporine after administration with grapefruit juice , 1995, Clinical pharmacology and therapeutics.
[23] U. Fuhr,et al. Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. , 1993, British journal of clinical pharmacology.
[24] L. Bertilsson,et al. Inhibition of the sulfoxidation of omeprazole by ketoconazole in poor and extensive metabolizers of S‐mephenytoin , 1997, Clinical pharmacology and therapeutics.
[25] L. Pickle,et al. The hydroxylation of omeprazole correlates with S‐mephenytoin metabolism: A population study , 1995, Clinical pharmacology and therapeutics.